Skip to content

An exploratory study on the curative effect of Xia's electrothermal needle in the treatment of chronic atrophic gastritis with intestinal metaplasia

An exploratory study on the curative effect of Xia's electrothermal needle in the treatment of chronic atrophic gastritis with intestinal metaplasia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085201
Enrollment
Unknown
Registered
2024-06-03
Start date
2024-06-03
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic atrophic gastritis with intestinal metaplasia

Interventions

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of chronic atrophic gastritis with intestinal metaplasia; (2) Prior to enrollment, electronic gastroscopy and histopathology confirmed atrophy (reduced intrinsic glands) with mild or moderate enterosis (intestinal metaplasia), with or without mild or moderate dysplasia; (2) Consistent with the TCM diagnosis and syndrome differentiation of chronic atrophic gastritis with intestinal metaplasia; (3) Gender is not limited, age between 18 and 75 years old; (4) The patient's informed consent and willingness to accept the appropriate treatment; (5) Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: (1) autoimmune gastritis; (2) Patients with other serious complications such as malignant tumors; (3) Gastric mucosa with high-grade intraepithelial neoplasia or suspected malignant transformation by pathological diagnosis; (4) Those who are taking aspirin, warfarin and other anticoagulants, or have coagulation disorders; (5) Patients with serious primary diseases such as heart, brain, liver, kidney, lung and blood system; (6) Women who are lactating or even pregnant; (7) Complicated with serious mental illness, unclear description of their own symptoms, unable to cooperate; (8) Patients who are participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
gastroscope ;pathological examination;Immunohistochemical detection;

Secondary

MeasureTime frame
Chronic atrophic gastritis PRO scale score ;TCM syndrome accumulation table ;

Countries

China

Contacts

Public ContactZhang Ping

Wangjing Hospital, China Academy of Chinese Medical Sciences

pinglele@sina.com+86 136 0138 2826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026